Stigmasterol suppresses skin cancer by increasing the lipid peroxide levels and causing DNA damage [16] and inhibits the development of cholangiocarcinoma via the downregulation of TNF-alpha and VEGFR-2 [14]. This evidence concerns the gene KDR and skin cancer.